AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

677.367

+6.0320.90%

Number of Gainers:7

Number of Losers:3

Number of Flat:33

PE:- -

High:680.034

Open:676.936

Low:675.368

Close:671.336

Volume:31.90M

Turnover:39.54M

Market Cap:96.73B

Float Cap:93.56B

Loading ...

CSL Seqirus to Supply UK with Aujemflu Flu Shot from 2027/28 Season

UK Extends Pandemic Vaccine Purchase Agreement with CSL Seqirus Through 2031

UK Government Strengthens Vaccine Partnership with CSL Seqirus, Introducing World-First Flu Vaccine (Ativc) and Extending Health Security Pandemic Agreement

THOMSON REUTERS

Immutep Plans Reverse Split of Nasdaq-Listed American Depositary Shares

MT Newswires Live

Immutep - Ads Ratio Changes to 1 Ads = 200 Ordinary Shares Effective Sept 28, 2026

THOMSON REUTERS

Immutep - Announces Change to Ads Ratio Quoted on NASDAQ

THOMSON REUTERS

Australian Shares End Flat as Miners Offset Gains in Banks

ASX Midday Sector Update: Healthcare Stocks Advance, Materials Sector Struggles

MT Newswires Live

Immutep Ltd-Change to American Depositary Share Ratio

THOMSON REUTERS

Orthocell Achieves First Commercial Sales of Nerve Repair Product in Thailand

MT Newswires Live

Prescient Therapeutics Says Trading Halt Requested

Australia's Orthocell Rises as Flagship Product Records First Thailand Sales

Paradigm Biopharmaceuticals Seeks Trading Halt

Prescient Therapeutics - Trading Halt Requested to Prepare Capital Raising Announcement

THOMSON REUTERS

Orthocell Ltd-Orthocell Achieves First Remplir Sales in Thailand

THOMSON REUTERS

Paradigm Biopharmaceuticals - Trading Halt Pending Interim Analysis Results for Phase 3 Clinical Trial

THOMSON REUTERS

Inhibitor Therapeutics Held Annual Shareholder Meeting, Elected Directors

PDI Gold And 2 Australian Founder Led Growth Stocks

Simply Wall St.

CSL Acknowledges Shareholder Frustration, Says Company Was Slow in Adapting to Competitive Pressures

MT Newswires Live

Polynovo Limited-Dean Phizacklea and Andrew Price Appointed to Pnv Board

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/stock/BK7508/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":677.3674,"timestamp":1790040803091,"preClose":671.3355,"halted":0,"volume":31899816,"delay":0,"changeRate":0.008985,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":6.03186,"latestTime":"09-22 11:33:25 AEST","open":676.93555,"high":680.0343,"low":675.3677,"amount":39541560,"amplitude":0.006951,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790056800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1790035200000,1790056800000]],"turnoverRate":0.001313,"increases":8,"decrements":3,"flats":30,"marketCap":96728735432.75,"floatMarketCap":93558995033.375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":680.0343,"amplitude":0.006951,"preClose":671.3355,"low":675.3677,"latestPrice":677.3674,"volume":31899816,"delay":0,"open":676.93555,"prevYearClose":644.3692,"prevWeekClose":661.778,"prevMonthClose":656.138,"prevQuarterClose":464.145,"fiveDayClose":659.123,"twentyDayClose":676.256,"sixtyDayClose":464.145,"secType":"PLATE","market":"AU","turnoverRate":0.001313,"marketCap":96728735432.75,"floatMarketCap":93558995033.375,"timestamp":1790040803091,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":7,"down":3,"flat":33},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669196695","title":"CSL Seqirus to Supply UK with Aujemflu Flu Shot from 2027/28 Season","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196695","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669196695?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:01","pubTimestamp":1790031677,"startTime":"0","endTime":"0","summary":"CSL Seqirus to supply UK with AUJEMFLU flu shot from 2027/28 seasonCSL unit Seqirus secured a UK rollout of its adjuvanted cell-based flu vaccine AUJEMFLU starting in the 2027/28 season.UKHSA extended","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL3qLMg2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7511","BK7501","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669698196","title":"UK Extends Pandemic Vaccine Purchase Agreement with CSL Seqirus Through 2031","url":"https://stock-news.laohu8.com/highlight/detail?id=2669698196","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669698196?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:01","pubTimestamp":1790031662,"startTime":"0","endTime":"0","summary":"UK extends pandemic vaccine purchase agreement with CSL Seqirus through 2031CSL’s Seqirus unit strengthened its partnership with the UK government, adding AUJEMFLU to the national flu program from 202","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL7ctxHt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","CSL.AU","BK7501","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196578","title":"UK Government Strengthens Vaccine Partnership with CSL Seqirus, Introducing World-First Flu Vaccine (Ativc) and Extending Health Security Pandemic Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196578","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669196578?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:00","pubTimestamp":1790031600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA7MQBBX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7067","BK7511","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669195643","title":"Immutep Plans Reverse Split of Nasdaq-Listed American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2669195643","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669195643?lang=en_us&edition=fundamental","pubTime":"2026-09-22 05:52","pubTimestamp":1790027561,"startTime":"0","endTime":"0","summary":"Immutep  said it will change the ratio of its Nasdaq-listed American depositary shares  to 1 ADS representing 200 ordinary shares from 1 ADS representing 10 ordinary shares, equivalent to a 1-for-20 ADS reverse split, effective Sept. 28, according to a late Monday statement by the company.The move is intended to help the company regain compliance with Nasdaq's $1 minimum bid-price requirement, following 30 consecutive business days of trading below that threshold.The change will not affect the company's Australian Securities Exchange-listed shares, share capital, cash position or clinical programs, while fractional ADSs will be sold and the proceeds distributed to eligible holders.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4107","BK7508","BK7016","NQmain","BK7067","LCLG","AFG","IMM.AU","ADS.AU","BK4117"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669316355","title":"Immutep - Ads Ratio Changes to 1 Ads = 200 Ordinary Shares Effective Sept 28, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669316355","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669316355?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:01","pubTimestamp":1789992111,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45A0RL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669163323","title":"Immutep - Announces Change to Ads Ratio Quoted on NASDAQ","url":"https://stock-news.laohu8.com/highlight/detail?id=2669163323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669163323?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:01","pubTimestamp":1789992111,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45A0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMM.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669531491","title":"Australian Shares End Flat as Miners Offset Gains in Banks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669531491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669531491?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:25","pubTimestamp":1789975555,"startTime":"0","endTime":"0","summary":"Australian shares end flat as miners offset gains in banksSept 21 (Reuters)-Australian shares ended little changed on Monday as gains in financials offset losses in commodity stocks, while expectation","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001143.SGD","BK5111","CBA.AU","LU1302929846.USD","CSL.AU","LU1487256676.USD","LU0612318971.USD","LU1309081286.SGD","TLX.AU","AN3PL.AU","LU0345777147.USD","LU0955623706.USD","ANZ.AU","LU2463526074.USD","COH.AU","LU0171293334.USD","LU0345777659.USD","LU0572939691.SGD","IE00BWDBJ516.SGD","LU1078025761.USD","LU1481599808.USD","LU0898667661.SGD","LU1046248800.SGD","BK7007","RIO.UK","LU0264606111.USD","LU0955648018.USD","LU1481600234.SGD","LU1023059493.AUD","LU0075056555.USD","LU0971552673.USD","BK7508","LU0345781412.USD","IE00BQJZX424.USD","RIO.AU","BK7067","LU0330918003.SGD","BK7511","LU0831103253.SGD","LU1064927863.SGD","BHP.AU","LU0654597011.USD","LU0788109121.HKD","LU0955669360.SGD","LU1430597077.USD","LU0456854461.SGD","SG9999002521.SGD","LU1130305938.SGD","LU0011963245.USD","LU0266512473.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669134802","title":"ASX Midday Sector Update: Healthcare Stocks Advance, Materials Sector Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2669134802","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669134802?lang=en_us&edition=fundamental","pubTime":"2026-09-21 11:36","pubTimestamp":1789961767,"startTime":"0","endTime":"0","summary":"Healthcare stocks advanced nearly 1% at midday Monday.CSL (ASX:CSL) gained more than 1% in recent trade.Meanwhile, the materials sector struggled, shedding almost 1%.BHP Group (ASX:BHP) shares were down nearly 1% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","XBI","LABU","UYM","BK7511","CSL.AU","LU0029874061.USD","BK7501","HCSG","LU0128526141.USD","BK4581","BK7507","BK7067","BK7095","BK4585","BHP.AU","BK4137","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669139744","title":"Immutep Ltd-Change to American Depositary Share Ratio","url":"https://stock-news.laohu8.com/highlight/detail?id=2669139744","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669139744?lang=en_us&edition=fundamental","pubTime":"2026-09-21 10:39","pubTimestamp":1789958383,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUE29TKJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMM.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669310139","title":"Orthocell Achieves First Commercial Sales of Nerve Repair Product in Thailand","url":"https://stock-news.laohu8.com/highlight/detail?id=2669310139","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669310139?lang=en_us&edition=fundamental","pubTime":"2026-09-21 10:06","pubTimestamp":1789956409,"startTime":"0","endTime":"0","summary":"Orthocell  achieved the first commercial sales of its nerve repair product, Remplir, in Thailand, according to a Monday Australian bourse filing.This follows the appointment of MediTime as the company's exclusive in-country distributor for Remplir in the country. Orthocel is supporting the launch and is working with MediTime to train representatives and build engagement.Its shares rose 2% in recent trading on Monday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OCC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669136567","title":"Prescient Therapeutics Says Trading Halt Requested","url":"https://stock-news.laohu8.com/highlight/detail?id=2669136567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669136567?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:28","pubTimestamp":1789954101,"startTime":"0","endTime":"0","summary":"BRIEF-Prescient Therapeutics Says Trading Halt RequestedSept 21 (Reuters)-Prescient Therapeutics LtdPTX.AX:TRADING HALT REQUESTED TO PREPARE CAPITAL RAISING ANNOUNCEMENTFurther company coverage:PTX.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45B00T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTX.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669364136","title":"Australia's Orthocell Rises as Flagship Product Records First Thailand Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2669364136","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669364136?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:22","pubTimestamp":1789953724,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Orthocell rises as flagship product records first Thailand sales** Shares of OrthocellOCC.AXrise as much as nearly 8% to A$0.745, marking their highest level since September 1** Share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D021:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","OCC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669135172","title":"Paradigm Biopharmaceuticals Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2669135172","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669135172?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:10","pubTimestamp":1789953056,"startTime":"0","endTime":"0","summary":"BRIEF-Paradigm Biopharmaceuticals Seeks Trading HaltSept 21 (Reuters)-Paradigm Biopharmaceuticals LtdPAR.AX:TRADING HALT PENDING INTERIM ANALYSIS RESULTS FOR PHASE 3 CLINICAL TRIALFurther company coverage:PAR.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45B00N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","PAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669145138","title":"Prescient Therapeutics - Trading Halt Requested to Prepare Capital Raising Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669145138","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669145138?lang=en_us&edition=fundamental","pubTime":"2026-09-21 07:34","pubTimestamp":1789947244,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260920:nFWN45B00T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","PTX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669099180","title":"Orthocell Ltd-Orthocell Achieves First Remplir Sales in Thailand","url":"https://stock-news.laohu8.com/highlight/detail?id=2669099180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669099180?lang=en_us&edition=fundamental","pubTime":"2026-09-21 06:56","pubTimestamp":1789944965,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260920:nTUE9JWLNM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","OCC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669764180","title":"Paradigm Biopharmaceuticals - Trading Halt Pending Interim Analysis Results for Phase 3 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669764180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669764180?lang=en_us&edition=fundamental","pubTime":"2026-09-21 06:48","pubTimestamp":1789944490,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260920:nFWN45B00N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PAR.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668978711","title":"Inhibitor Therapeutics Held Annual Shareholder Meeting, Elected Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2668978711","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668978711?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:01","pubTimestamp":1789761667,"startTime":"0","endTime":"0","summary":"Inhibitor Therapeutics held annual shareholder meeting, elected directorsInhibitor Therapeutics held its annual stockholders meeting on Sept. 15, 2026.Stockholders selected six directors for one-year ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL1klb8j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","INTI","MYX.AU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668888661","title":"PDI Gold And 2 Australian Founder Led Growth Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2668888661","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668888661?lang=en_us&edition=fundamental","pubTime":"2026-09-19 00:29","pubTimestamp":1789748965,"startTime":"0","endTime":"0","summary":"Central banks are lifting interest rates again, and history shows that higher borrowing costs often hit fast growers hardest. Australian companies where founders and executives hold big stakes can sometimes weather that pressure better, because management feels every share price move in their own net worth. This article looks at three fast growing, high insider ownership stocks from our screener and explains why each might deserve a spot on your watchlist.\nThe three stocks below are just a...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2053000-choice2-card/1788948823050","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2053000-choice2-card/1788948823050"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/pdi-gold-and-2-australian-founder-led-growth-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/pdi-gold-and-2-australian-founder-led-growth-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["USD.AU","BK4139","IIGF.AU","BK7508","PDI","OZR.AU","PDI.AU","BEAR.AU","DACE.AU","QRE.AU","TLX.AU","OZF.AU","XKO.AU","BK7501","BK7067","IMLC.AU","GIVE.AU","QFN.AU","SLF.AU","BBOZ.AU","IOZ.AU","STW.AU","EIGA.AU","XJO.AU","USD","VAS.AU","MSB.AU","VAP.AU","IISV.AU","TLX","GEAR.AU","E200.AU","XAO.AU","BK7104","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668251934","title":"CSL Acknowledges Shareholder Frustration, Says Company Was Slow in Adapting to Competitive Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2668251934","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668251934?lang=en_us&edition=fundamental","pubTime":"2026-09-17 08:34","pubTimestamp":1789605262,"startTime":"0","endTime":"0","summary":"CSL's  board acknowledged shareholder frustration over the company's \"disappointing\" commercial and financial performance, saying it aims to win back their trust by delivering results, according to a Thursday filing with the Australian bourse.The company pointed to a multibillion-dollar statutory loss driven by restructuring, a pending leadership transition, and the recognition of substantial non-cash balance sheet impairments as issues that have vexed shareholders.\"We built up substantial fixed costs, we were slow to adapt to competitive pressures, our research and development efforts didn't deliver and some investments the company made did not perform,\" the biotechnology company said in a notice for its annual general meeting scheduled for Oct. 27.CSL leadership is \"acting with urgency\" to address these issues through a strategy to invest in the core of its plasma business, with only selective investment beyond that area.\"We must adapt more rapidly as markets evolve and ensure our in","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7511","BK7067","BK7501","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668693985","title":"Polynovo Limited-Dean Phizacklea and Andrew Price Appointed to Pnv Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2668693985","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668693985?lang=en_us&edition=fundamental","pubTime":"2026-09-17 06:23","pubTimestamp":1789597397,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUE77J5M1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","BK7508","PNV.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":68,"code":"91000000","status":"200"}]}}